Bottom line
FRBRX vs RYOIX: the short answer
FRBRX (Franklin Biotechnology Discovery Fund) and RYOIX (Biotechnology Fund) are both mutual funds.
FRBRX is cheaper at 0.67% vs 1.38% — a difference of $71 a year per $10,000 invested.
Over five years, FRBRX returned +6.6% a year vs +4.0% for RYOIX.
Updated Nov 19, 2026
FRBRX vs RYOIX side by side
| FRBRX | RYOIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Franklin Templeton | Guggenheim |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.67% | 1.38% |
| Annual cost per $10k | $67 | $138 |
| 10-yr cost on $10k (prospectus) | $955 | $1,709 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +52.8% | +30.7% |
| 5-yr return (annualized) | +6.6% | +4.0% |
| 10-yr return (annualized) | +7.4% | +5.9% |
| Best quarter | — | +28.3% |
| Worst quarter | — | −22.5% |
| Net assets (fund) | $1.2B | $136.8M |
| Number of holdings | 126 | 74 |
| Portfolio turnover | 38% | 75% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
12 of FRBRX's top 25 holdings also appear in RYOIX's top 25.
| Holding | FRBRX | RYOIX |
|---|---|---|
| Jazz Pharmaceuticals plc | 5.66% | 1.42% |
| Amgen, Inc. | 4.39% | 5.05% |
| Gilead Sciences, Inc. | 3.86% | 4.49% |
| Regeneron Pharmaceuticals, Inc. | 3.77% | 2.93% |
| Argenx SE | 3.62% | 1.48% |
| Vertex Pharmaceuticals, Inc. | 3.54% | 4.32% |
| Revolution Medicines, Inc. | 3.01% | 2.48% |
| Guardant Health, Inc. | 2.76% | 1.72% |
| Insmed, Inc. | 1.99% | 1.79% |
| Neurocrine Biosciences, Inc. | 1.82% | 1.52% |
| Bridgebio Pharma, Inc. | 1.67% | 1.38% |
| Cytokinetics, Inc. | 1.24% | 1.35% |
Source: SEC Form N-PORT
FRBRX top 10
- Jazz Pharmaceuticals plc — 5.66%
- Amgen, Inc. — 4.39%
- Gilead Sciences, Inc. — 3.86%
- Regeneron Pharmaceuticals, Inc. — 3.77%
- Argenx SE — 3.62%
- Vertex Pharmaceuticals, Inc. — 3.54%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Revolution Medicines, Inc. — 3.01%
- Guardant Health, Inc. — 2.76%
- Ascendis Pharma A/S — 2.56%
RYOIX top 10
- Abbvie Inc — 8.17%
- Amgen Inc — 5.05%
- Gilead Sciences Inc — 4.49%
- Vertex Pharmaceuticals Inc — 4.32%
- Regeneron Pharmaceuticals Inc — 2.93%
- Revolution Medicines Inc — 2.48%
- Alnylam Pharmaceuticals Inc — 2.36%
- Beone Medicines Ltd — 2.17%
- Moderna Inc — 2.15%
- Biogen Inc — 2.13%
FAQ
What is the difference between FRBRX and RYOIX?
FRBRX (Franklin Biotechnology Discovery Fund) and RYOIX (Biotechnology Fund) are both mutual funds. FRBRX is cheaper at 0.67% vs 1.38% — a difference of $71 a year per $10,000 invested.
Which is cheaper, FRBRX or RYOIX?
FRBRX has the lower expense ratio (0.67%).
Should I own both FRBRX and RYOIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.